116 related articles for article (PubMed ID: 18714530)
21. Association between (CCTTT)n repeat polymorphism in NOS2 promoter and asthma exacerbations.
Hirai K; Shirai T; Suzuki M; Shimomura T; Itoh K
J Allergy Clin Immunol; 2018 Aug; 142(2):663-665.e3. PubMed ID: 29518423
[No Abstract] [Full Text] [Related]
22. The (CCTTT)n microsatellite polymorphism in the nitric oxide synthase 2 gene may influence bladder cancer pathogenesis.
Ryk C; Steineck G; Wiklund NP; Nyberg T; de Verdier PJ
J Urol; 2010 Nov; 184(5):2150-7. PubMed ID: 20850837
[TBL] [Abstract][Full Text] [Related]
23. Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease.
Xu W; Humphries S; Tomita M; Okuyama T; Matsuki M; Burgner D; Kwiatkowski D; Liu L; Charles IG
Nitric Oxide; 2000 Aug; 4(4):379-83. PubMed ID: 10944422
[TBL] [Abstract][Full Text] [Related]
24. Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population.
Tajouri L; Martin V; Ovcaric M; Curtain RP; Lea RA; Csurhes P; Pender MP; Griffiths LR
Brain Res Bull; 2004 Jul; 64(1):9-13. PubMed ID: 15275951
[TBL] [Abstract][Full Text] [Related]
25. Role of polymorphisms of inducible nitric oxide synthase and endothelial nitric oxide synthase in idiopathic environmental intolerances.
De Luca C; Gugliandolo A; Calabrò C; Currò M; Ientile R; Raskovic D; Korkina L; Caccamo D
Mediators Inflamm; 2015; 2015():245308. PubMed ID: 25878398
[TBL] [Abstract][Full Text] [Related]
26. The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies.
Xu W; Liu L; Emson P; Harrington CR; McKeith IG; Perry RH; Morris CM; Charles IG
Neuroreport; 2000 Feb; 11(2):297-9. PubMed ID: 10674474
[TBL] [Abstract][Full Text] [Related]
27. CCTTT pentanucleotide repeats in inducible nitric oxide synthase gene expression in patients with pulmonary arterial hypertension.
Baloira Villar A; Pousada Fernández G; Vilariño Pombo C; Núñez Fernández M; Cifrián Martínez J; Valverde Pérez D
Arch Bronconeumol; 2014 Apr; 50(4):141-5. PubMed ID: 24439467
[TBL] [Abstract][Full Text] [Related]
28. Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in northwestern Spain.
Martin J; Paco L; Ruiz MP; Lopez-Nevot MA; Garcia-Porrua C; Amoli MM; Calviño MC; Ollier WE; Gonzalez-Gay MA
J Rheumatol; 2005 Jun; 32(6):1081-5. PubMed ID: 15940772
[TBL] [Abstract][Full Text] [Related]
29. Genetic association analysis of CIITA variations with nasal polyp pathogenesis in asthmatic patients.
Bae JS; Pasaje CF; Park BL; Cheong HS; Kim JH; Uh ST; Park CS; Shin HD
Mol Med Rep; 2013 Mar; 7(3):927-34. PubMed ID: 23292525
[TBL] [Abstract][Full Text] [Related]
30. Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma.
Sekigawa T; Tajima A; Hasegawa T; Hasegawa Y; Inoue H; Sano Y; Matsune S; Kurono Y; Inoue I
Clin Exp Allergy; 2009 Jul; 39(7):972-81. PubMed ID: 19489917
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase-9 promoter gene polymorphism (-1562C>T) in nasal polyposis.
Erbek SS; Yurtcu E; Erbek S; Sahin FI
Am J Rhinol Allergy; 2009; 23(6):568-70. PubMed ID: 19958602
[TBL] [Abstract][Full Text] [Related]
32. Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand.
Ohashi J; Naka I; Patarapotikul J; Hananantachai H; Looareesuwan S; Tokunaga K
J Infect Dis; 2002 Aug; 186(4):578-81. PubMed ID: 12195390
[TBL] [Abstract][Full Text] [Related]
33. Preliminary evidences of a NOS2A protective effect from relapsing-remitting multiple sclerosis.
Manna I; Liguori M; Valentino P; Condino F; La Russa A; Clodomiro A; Nisticò R; Di Palma G; Quattrone A
J Neurol Sci; 2008 Jan; 264(1-2):112-7. PubMed ID: 17854833
[TBL] [Abstract][Full Text] [Related]
34. Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter.
Tatemichi M; Sawa T; Gilibert I; Tazawa H; Katoh T; Ohshima H
Cancer Lett; 2005 Jan; 217(2):197-202. PubMed ID: 15617837
[TBL] [Abstract][Full Text] [Related]
35. The (CCTTT) n pentanucleotide repeat polymorphism in the inducible nitric oxide synthase gene promoter and the risk of psoriasis in Taiwanese.
Chang YC; Wu WM; Huang YH; Chung WH; Tsai HY; Hsu LA
Arch Dermatol Res; 2015 Jul; 307(5):425-32. PubMed ID: 25663087
[TBL] [Abstract][Full Text] [Related]
36. Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility.
Martín MC; Martinez A; Mendoza JL; Taxonera C; Díaz-Rubio M; Fernández-Arquero M; de la Concha EG; Urcelay E
Immunogenetics; 2007 Nov; 59(11):833-7. PubMed ID: 17955236
[TBL] [Abstract][Full Text] [Related]
37. [Polymorphism of NOS2A promoter -969(G>C) is associated with portal hypertension of liver cirrhosis].
Cheng YQ; Wang WQ; Lin JS; Xiong P; Jiang XD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):591-5. PubMed ID: 15583989
[TBL] [Abstract][Full Text] [Related]
38. Lack of association between the glutathione-s-transferase genes (GSTT1 and GSTM1) and nasal polyposis.
Arbag H; Cora T; Acar H; Ozturk K; Sari F; Ulusoy B
Rhinology; 2006 Mar; 44(1):14-8. PubMed ID: 16550944
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive association analysis of the NOS2A gene with Parkinson disease.
Schulte C; Sharma M; Mueller JC; Lichtner P; Prestel J; Berg D; Gasser T
Neurology; 2006 Dec; 67(11):2080-2. PubMed ID: 17159127
[TBL] [Abstract][Full Text] [Related]
40. NO role of NOS2A susceptibility polymorphisms in rheumatoid arthritis.
Varadé J; Lamas JR; Fernández-Arquero M; Jover JA; de la Concha EG; Martínez A; Fernández-Gutierrez B; Urcelay E
Nitric Oxide; 2009; 21(3-4):171-4. PubMed ID: 19635578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
